{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T17:36:14Z","timestamp":1769448974833,"version":"3.49.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    The pathogenesis of systemic lupus erythematosus (SLE) is caused by a complex mix of genetic factors that lead to dysregulation of the immune response. Mild susceptibility or resistance factors can tilt the scale towards or against pathology. Here, we present evidence for the\n                    <jats:italic>Irf8<\/jats:italic>\n                    gene as a lupus protective factor in conditions of haploinsufficiency or mosaicism. We targeted\n                    <jats:italic>Irf8<\/jats:italic>\n                    expression in mice deficient in\n                    <jats:italic>Fcgr2b<\/jats:italic>\n                    , a well characterized mouse model of SLE. As is the case in human SLE, hyperresponsive B cells and dendritic cells (DCs) are causal factors at various stages of disease in\n                    <jats:italic>Fcgr2b<\/jats:italic>\n                    -deficient mice (\n                    <jats:italic>\n                      R2\n                      <jats:sup>-\/-<\/jats:sup>\n                    <\/jats:italic>\n                    ). Since\n                    <jats:italic>Irf8<\/jats:italic>\n                    is essential for the generation of cDC1s, we used conditional deletion with various known DC-targeting Cre systems to delete\n                    <jats:italic>Irf8<\/jats:italic>\n                    . All conditional systems tested to delete\n                    <jats:italic>Irf8<\/jats:italic>\n                    reduced the titer of antinuclear antibodies and abrogated kidney pathology in\n                    <jats:italic>\n                      R2\n                      <jats:sup>-\/-<\/jats:sup>\n                    <\/jats:italic>\n                    mice. In addition to the expected effect of\n                    <jats:italic>Irf8<\/jats:italic>\n                    deletion in cDC1s, we unexpectedly found that mosaic deletion of\n                    <jats:italic>Irf8<\/jats:italic>\n                    also occurred in B cells and other immune cells. Using mixed bone marrow chimeras we determined that the aborted disease in\n                    <jats:italic>\n                      Irf8\n                      <jats:sup>f\/f<\/jats:sup>\n                      CD11c-Cre+R2\n                      <jats:sup>-\/-<\/jats:sup>\n                    <\/jats:italic>\n                    and\n                    <jats:italic>\n                      Irf8\n                      <jats:sup>f\/f<\/jats:sup>\n                      Itgax-Cre+R2\n                      <jats:sup>-\/-<\/jats:sup>\n                    <\/jats:italic>\n                    mice could be attributed to the inability of B cells with partial reduction of IRF8 to produce autoantibodies. Therefore, these results reveal IRF8 as a susceptibility factor of SLE even in cases of mild changes of expression levels and mosaic somatic deletion of the gene in B cells.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2025.1662894","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T07:11:35Z","timestamp":1769411495000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["CD11c-Cre driven deletion of Irf8 reveals the effect of somatic mosaicism in a mouse model of SLE"],"prefix":"10.3389","volume":"16","author":[{"given":"Hongsheng","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Feng","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bethany","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hemanta","family":"Kole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Bolland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000412","article-title":"An update on lupus animal models","volume":"29","author":"Li","year":"2017","journal-title":"Curr Opin Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e000199","DOI":"10.1136\/lupus-2016-000199","article-title":"Mouse models of lupus: what they tell us and what they don\u2019t","volume":"5","author":"Richard","year":"2018","journal-title":"Lupus Sci Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1080\/17460441.2022.2050691","article-title":"Animal models of systemic lupus erythematosus and their applications in drug discovery","volume":"17","author":"Xin","year":"2022","journal-title":"Expert Opin Drug Discov"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)00027-3","article-title":"Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis","volume":"13","author":"Bolland","year":"2000","journal-title":"Immunity"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.ircmb.2019.07.004","article-title":"Dendritic cell subsets and locations","volume":"348","author":"Balan","year":"2019","journal-title":"Int Rev Cell Mol Biol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"100066","DOI":"10.1016\/j.jtauto.2020.100066","article-title":"cDC1 are required for the initiation of collagen-induced arthritis","volume":"3","author":"Ramos","year":"2020","journal-title":"J Transl Autoimmun"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15961","article-title":"Conventional type 1 dendritic cells are essential for the development of primary biliary cholangitis","volume":"44","author":"Reuveni","year":"2024","journal-title":"Liver Int"},{"key":"B8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.molimm.2020.02.021","article-title":"Transcriptional regulation of DC fate specification","volume":"121","author":"Bosteels","year":"2020","journal-title":"Mol Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20021263","article-title":"ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8alpha(+) dendritic cells","volume":"196","author":"Schiavoni","year":"2002","journal-title":"J Exp Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.08.013","article-title":"IRF8 transcription factor controls survival and function of terminally differentiated conventional and plasmacytoid dendritic cells, respectively","volume":"45","author":"Sichien","year":"2016","journal-title":"Immunity"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1501870","article-title":"IRF4 and IRF8 act in CD11c+ Cells to regulate terminal differentiation of lung tissue dendritic cells","volume":"196","author":"Bajana","year":"2016","journal-title":"J Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3197","article-title":"Batf3 maintains autoactivation of Irf8 for commitment of a CD8alpha(+) conventional DC clonogenic progenitor","volume":"16","author":"Grajales-Reyes","year":"2015","journal-title":"Nat Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.02.008","article-title":"IRF8 transcription-factor-dependent classical dendritic cells are essential for intestinal T cell homeostasis","volume":"44","author":"Luda","year":"2016","journal-title":"Immunity"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1901258116","article-title":"Transcription factors IRF8 and PU.1 are required for follicular B cell development and BCL6-driven germinal center responses","volume":"116","author":"Wang","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-008-8055-8","article-title":"IRF8 regulates myeloid and B lymphoid lineage diversification","volume":"43","author":"Wang","year":"2009","journal-title":"Immunol Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2020.04.011","article-title":"Transcriptional control of mature B cell fates","volume":"41","author":"Wang","year":"2020","journal-title":"Trends Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1186\/s12887-024-05208-w","article-title":"Brain abscess caused by Streptococcus pyogenes with atypical symptoms: a case report and literature review","volume":"24","author":"Hua","year":"2024","journal-title":"BMC Pediatr"},{"key":"B18","doi-asserted-by":"crossref","first-page":"e1002341","DOI":"10.1371\/journal.pgen.1002341","article-title":"Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus","volume":"7","author":"Cunninghame Graham","year":"2011","journal-title":"PloS Genet"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20140425","article-title":"The transcription factors IRF8 and PU.1 negatively regulate plasma cell differentiation","volume":"211","author":"Carotta","year":"2014","journal-title":"J\u00a0Exp Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1104803","article-title":"IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development","volume":"17","author":"Lu","year":"2003","journal-title":"Genes Dev"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1001950","article-title":"IFN regulatory factor 8 restricts the size of the marginal zone and follicular B cell pools","volume":"186","author":"Feng","year":"2011","journal-title":"J Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"4813","DOI":"10.1038\/s41467-021-25102-8","article-title":"Altered function and differentiation of age-associated B cells contribute to the female bias in lupus mice","volume":"12","author":"Ricker","year":"2021","journal-title":"Nat Commun"},{"key":"B23","doi-asserted-by":"publisher","first-page":"105121","DOI":"10.1016\/j.meegid.2021.105121","article-title":"Identification of a novel IRF8 homozygous mutation causing neutrophilia, monocytopenia and fatal infection in a female neonate","volume":"96","author":"Dang","year":"2021","journal-title":"Infect Genet Evol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.immuni.2020.07.018","article-title":"High amount of transcription factor IRF8 engages AP1-IRF composite elements in enhancers to direct type 1 conventional dendritic cell identity","volume":"53","author":"Kim","year":"2020","journal-title":"Immunity"},{"key":"B25","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.immuni.2020.07.003","article-title":"Differential IRF8 transcription factor requirement defines two pathways of dendritic cell development in humans","volume":"53","author":"Cytlak","year":"2020","journal-title":"Immunity"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-00871-y","article-title":"A RUNX-CBFbeta-driven enhancer directs the Irf8 dose-dependent lineage choice between DCs and monocytes","volume":"22","author":"Murakami","year":"2021","journal-title":"Nat Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1172\/JCI86276","article-title":"Biallelic mutations in IRF8 impair human NK cell maturation and function","volume":"127","author":"Mace","year":"2017","journal-title":"J Clin Invest"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20062648","article-title":"Notch-RBP-J signaling controls the homeostasis of CD8- dendritic cells in the spleen","volume":"204","author":"Caton","year":"2007","journal-title":"J Exp Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2007.03.016","article-title":"Elimination of antigen-presenting cells and autoreactive T cells by Fas contributes to prevention of autoimmunity","volume":"26","author":"Stranges","year":"2007","journal-title":"Immunity"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2611-3","article-title":"cDC1 prime and are licensed by CD4(+) T cells to induce anti-tumour immunity","volume":"584","author":"Ferris","year":"2020","journal-title":"Nature"},{"key":"B31","article-title":"Purification and analysis of kidney-infiltrating leukocytes in a mouse model of lupus nephritis","volume":"188","author":"Amo","year":"2024","journal-title":"Method Cell Biol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02452","article-title":"Antiviral adaptor MAVS promotes murine lupus with a B cell autonomous role","volume":"10","author":"Sun","year":"2019","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.11.023","article-title":"Revision of the International Society of Nephrology\/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices","volume":"93","author":"Bajema","year":"2018","journal-title":"Kidney Int"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1172\/JCI148000","article-title":"CCL17-producing cDC2s are essential in end-stage lupus nephritis and averted by a parasitic infection","volume":"131","author":"Amo","year":"2021","journal-title":"J Clin Invest"},{"key":"B35","doi-asserted-by":"publisher","first-page":"113600","DOI":"10.1016\/j.jim.2023.113600","article-title":"Variegate expression of Cre recombinase in hematopoietic cells in CD11c-cre transgenic mice","volume":"525","author":"Murat","year":"2024","journal-title":"J Immunol Methods"},{"key":"B36","doi-asserted-by":"publisher","first-page":"109295","DOI":"10.1016\/j.clim.2023.109295","article-title":"Attenuation of renal injury by depleting cDC1 and by repurposing Flt3 inhibitor in anti-GBM disease","volume":"250","author":"Chen","year":"2023","journal-title":"Clin Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12741","article-title":"Extrafollicular responses in humans and SLE","volume":"288","author":"Jenks","year":"2019","journal-title":"Immunol Rev"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2008.03.014","article-title":"Peripheral B cell subsets","volume":"20","author":"Allman","year":"2008","journal-title":"Curr Opin Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1662894\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T07:11:36Z","timestamp":1769411496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1662894\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,26]]},"references-count":38,"alternative-id":["10.3389\/fimmu.2025.1662894"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1662894","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,26]]},"article-number":"1662894"}}